MoonLake Immunotherapeutics (NASDAQ: MLTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MOONLAKE IMMUNOTHERAPEUTICS

MoonLake Immunotherapeutics (NASDAQ: MLTX)
Listen to this Section


$20.35
-0.0100 ( -0.05% ) 1.5K

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Market Data


Open $20.35
Previous Close $20.36
Volume 1.5K
Market Cap $1.70B
Day Range $20.31 - $20.77
52 Week Range $5.95 - $62.75
Shares Outstanding 83.56M
Change % -0.05%
Net Change ▼ -0.0100
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2022
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 21,740.00

Date Type Amount Purchased Purchaser
2025-10-09 Buy 10870.00 Bodenstedt Matthias
2025-10-09 Buy 10870.00 Bodenstedt Matthias

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 86 Nov 05, 2025
8-k 8K-related 13 Nov 05, 2025
8-k 8K-related 15 Nov 05, 2025
4 Insider transactions 1 Oct 09, 2025
4 Insider transactions 1 Oct 01, 2025
8-k 8K-related 14 Sep 29, 2025
4 Insider transactions 1 Sep 04, 2025
8-k 8K-related 13 Aug 05, 2025
10-q Quarterly Reports 87 Aug 05, 2025
4 Insider transactions 1 Jul 07, 2025

Latest News